Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Infectious Diseases|May 21, 2013
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmissionSaran Vardhanabhuti, Edward P Acosta, Heather J Ribaudo, et al.Plos One|May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infectionEric S Rosenberg, Barney S Graham, Ellen S Chan, et al.Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.Nature Medicine|July 15, 2009
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1Angela Meier, J Judy Chang, Ellen S Chan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.Vaccine|May 20, 2009
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapyRajesh T Gandhi, David O'Neill, Ronald J Bosch, et al.The Journal of Infectious Diseases|April 28, 2010
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trialDavid M Asmuth, Robert L Murphy, Susan L Rosenkranz, et al.Pageof 3